Triton Systems is a Global Business Venture company that successfully launches innovative products and solutions in emerging markets worldwide. We invest in new technologies through in-house incubation and external partnerships – creating thriving businesses from novel ideas.

Business Ventures

Ventures Include:

Aduro Biotech

Aduro Biotech (Aduro), a Triton launched company formed in 2010, stays at the forefront of discovery, development and commercialization of immunotherapies, alone or in combination; that make transformative advances in the treatment of challenging diseases.

FRX Polymers, Inc.

FRX Polymers, Inc., a (formed by Triton in 2007) manufactures Nofia® polyphosphonates - fire resistant plastics. Nofia products are fully transparent, high flowing and, due to their high phosphorus content, are inherently flame retardant. 

Fluence

Fluence specializes in developing energy-efficient wastewater treatment solutions. The company’s innovative Membrane Aerated Biofilm Reactor (MABR) technology is installed at sites around the world.

Sensera

Sensera is an integrated, fast turnaround client-specific designer and manufacturer of specialized high performance microsensors and micro-fabricated components for the Healthcare, Industrial, Defense and Aerospace markets.

Emerging Technologies

Key to our process is to research, identify and incubate emerging technologies that are in line with our strategic market focus. Through our in-house incubation operations or through outside partnerships and adopted technologies, we provide market driven solutions that effect the world around us. Emerging technologies include:

Featured Incubated Products

Traceptor™ Preconcentrator

A Plug and Play ‘Sensitivity Amplifier’ that enables chemical sensors for threat and contraband detection.

MEMS Sensors & Manufacturing

Sensera designs, engineers and manufactures MEMS-based sensors and other devices for industrial, medical and defense applications.

FRA Composites
(Fiber Reinforced Aluminum)

Triton FRA Composites is a fiber reinforced aluminum composite that offers light weight and high strength alternatives to heavy steel for bearing applications.

Latest News

Triton Chairman and CEO Wins Entrepreneur of the Year Award

May 7, 2018: Business executive, serial entrepreneur, and venture capitalist Ross Haghighat has been honored as “Entrepreneur of the Year” at the 2018 Enterprise Bank Celebration of Excellence Awards. To view award speech:   https://www.youtube.com/watch?v=w8eJJFblTOM&list=PLcuJZStD3-vXnC-WzxK0LjBmz2JA5o2GP

 

Triton Systems New Company Video

To celebrate Triton's 25 Years in Busines, Triton launched a new video showcasing it's accomplishments, technologists and the vision of the company for the next generation of innovation. To view: https://www.youtube.com/watch?v=rOETFI7EJ3k

 

 

 

Nanotron and ClearBlade build Location Data Analytics partnership to take real – time tracking to the next level

WOBURN, MA, April 10, 2018: : Sensera’s wholly owned German subsidiary Nanotron Technologies GmbH and enterprise IoT platform provider ClearBlade, Inc. today announced a partnership to add ClearBlade’s industry-leading IoT and Edge Computing platform to nanotron’s advanced tracking software.

Read More

 

 

Aduro Biotech Highlights Preclinical Data for Three Programs Reported at the American Association for Cancer Research Annual Meeting

BERKELEY, Calif., April 16, 2018 (GLOBE NEWSWIRE) --BERKELEY, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that data from three of the company’s programs were presented at the American Association for Cancer Research (AACR) this week. The poster presentations detailed:

  • Updated preclinical data for ADU-S100, a first-in-class small molecule therapeutic in Phase 1 studies targeting the STimulator of INterferon Genes (STING) pathway;
  • New preclinical data for ADU-1604, an anti-CTLA-4 antibody scheduled to enter clinical development in the second half of 2018; and,
  • Preclinical data for BION-1301, an anti-APRIL antibody currently in a Phase 1/2 study for the treatment of patients with multiple myeloma.

Read More

 

Fluence Unveils its Aspiral™ Family of Wastewater Treatment Solutions

NEW YORK, May 1, 2018: Fluence Corporation Limited (ASX: FLC) (“Fluence” or the “Company”), is pleased to unveil its Aspiral™ family of decentralized, smart packaged wastewater treatment solutions, based on its innovative Membrane Aerated Biofilm Reactor (MABR) technology. Fluence MABR is a spirally wound, self-respiring membrane that provides aeration for the wastewater process and functions as the biological reactor.

Read More